Intervention Review

Steroid hormones for contraception in women with sickle cell disease

  1. Anu Manchikanti Gomez1,*,
  2. David A Grimes2,
  3. Laureen M Lopez2,
  4. Kenneth F Schulz3

Editorial Group: Cochrane Fertility Regulation Group

Published Online: 18 APR 2007

DOI: 10.1002/14651858.CD006261.pub2


How to Cite

Manchikanti Gomez A, Grimes DA, Lopez LM, Schulz KF. Steroid hormones for contraception in women with sickle cell disease. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006261. DOI: 10.1002/14651858.CD006261.pub2.

Author Information

  1. 1

    Gillings School of Global Public Health, Department of Maternal and Child Health, Chapel Hill, North Carolina, USA

  2. 2

    FHI 360, Clinical Sciences, Research Triangle Park, North Carolina, USA

  3. 3

    FHI 360 and UNC School of Medicine, Quantitative Sciences, Research Triangle Park, North Carolina, USA

*Anu Manchikanti Gomez, Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, CB 7445, Chapel Hill, North Carolina, 27599, USA. anupama@unc.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 18 APR 2007

SEARCH

  1. Current Version

    Steroid hormones for contraception in women with sickle cell disease

    Anu Manchikanti Gomez, David A Grimes, Laureen M Lopez and Kenneth F Schulz

    Version of Record online: 18 APR 2007 | DOI: 10.1002/14651858.CD006261.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Steroid hormones for contraception in women with sickle cell disease

    Anu Manchikanti, David A Grimes, Laureen M Lopez and Kenneth F Schulz

    Version of Record online: 18 OCT 2006 | DOI: 10.1002/14651858.CD006261